Eli Lilly to build a USD 2.5-billion plant in Germany

US-based Eli Lilly is planning a huge investment of USD 2.5 billion, equivalent to around SEK 26.5 billion, in a new production facility in Alzey, Germany.

Automated opening and closing of sample vials

From technical requirements to a suitable solution

Collaboration in laboratory automation

The Dutch company Synchron Lab Automation developed an automated DNA extraction system with high throughput, working very closely together with Festo. As a resu...

Anpassningsbara vridspjällsventiler från OMAL – lösningen för tuffa miljöer

OEM Automatic erbjuder nu vridspjällsventiler från OMAL, särskilt utvecklade för att möta höga krav inom industriella applikationer. Med hög driftsäkerhet, lång...

A new international stem cell research centre has been created in Copenhagen

A new centre for stem cell research opened to the public in January. The Novo Nordisk Foundation backs the initiative with the ambition that the centre will adv...

Decades of research destroyed at KI – a hacker attack cannot be ruled out!

Years of research, together with half a billion Swedish krona, went up in smoke when the freezers at Karolinska Institutet overheated. The breakdown has now bee...

The first Lyme disease vaccine faces a delay

Pfizer and Valneva’s Lyme disease vaccine, which could be the first of its kind, is facing delays of about a year. The reason is problems at trial sites in the ...

NorthX Biologics Matfors AB

ZEISS Quality Innovation Summit video

An event full of experiences, talks, innovations, speeches, and state-of-the-art technology.

“We aim to be a start-up company with an academic spirit”

Chronic pain and Alzheimer’s are two diseases that plague many people worldwide and seem impossible to cure. However, Huddinge-based company Alzecure is working...

Artificial intelligence in radiology – “Risk prediction is very exciting”

A growing number of solutions based on artificial intelligence are being developed and used in healthcare. According to Sophia Zackrisson, Professor of Radiolog...

ZEISS presents the "Quality Innovation Summit"

A global event on the future of quality assurance.

BMS subkutana cancerläkemedel godkänt i EU

För första gången har en PD-1-hämmare godkänns för subkutan administrering inom EU. Det handlar om cancerläkemedlet Opdivo, utvecklat av amerikanska Bristol Myers Squibb (BMS).

Sahlgrenska Science Park

Pharma Relations AB

Explore our tailored program for Control 2025

Choose an innovation tour, or join our industry-specific guided tours.

Non-destructive testing and assembly control

Assess complete assembly.

Festo Expands its Portfolio with Multilayer Manifolds

Manufacturers of medical and laboratory equipment now receive solutions from a single source

ALS – When the body has given up, but the brain persists

The nerve disease ALS gradually deprives the patient of control over the muscles and, eventually, also of speech. The eyes continue to function, though, and wit...

Novo Nordisk to invest billions in new quality control lab

Novo Nordisk has announced plans to invest 2.9 billion Danish kroner in order to establish a new quality control laboratory in Hillerød in northern Zealand, Denmark.

Scale Up Your Image Analysis

ZEISS arivis Hub for accelerated analysis and faster results.

Sobi announces agreement with Enable Injections

Swedish biopharma Sobi has entered into an international development and distribution agreement with US drug delivery company Enable Injections.

Bud på Biotage – värderas till över 11 miljarder

Uppsalabaserade Biotage meddelade på tisdagen att det amerikanska investmentbolaget KKR har lagt ett kontantbud på biotechbolaget.

Italian pharmaceutical company buys rights to immunotherapy from Sanofi

Italy's Recordati buys the rights to a treatment for the rare autoimmune disease cold agglutinin disease (CAD).